Login or sign up
For business

Translational Biochemistry and Metabolomics (TBM)

3.8· 5 reviews
Average ratingAverage
3.8/ 5

Based on 5 reviews

540%
440%
30%
20%
120%
Ask AI

Questions about Translational Biochemistry and Metabolomics (TBM)

Based on 5 reviews, listing data and website checks · updated 9 days ago

What is Translational Biochemistry and Metabolomics (TBM)?

Translational Biochemistry and Metabolomics (TBM) is an international, peer-reviewed, open-access scientific journal that publishes research at the interface of biochemistry, metabolomics, molecular medicine, and clinical translation. It serves as a multidisciplinary platform for studies examining the biochemical and metabolic mechanisms of health and disease, with an emphasis on translating molecular discoveries into biomarkers, diagnostics, therapies, and precision-medicine applications.

How does the submission process work for authors?

TBM is published three times a year with regular issues released in January, May, and September. The journal operates a free-format initial submission policy, meaning manuscripts are not required to comply fully with specific font, spacing, or page-layout requirements at the initial stage. Authors can submit manuscripts prepared according to the format of another recognised scientific journal as long as they are complete and readable.

Are there any costs for authors to publish their work?

The journal does not charge authors any submission, processing, peer-review, publication, or article processing fees. All manuscripts are evaluated and, if accepted, published entirely free of charge. There are no Article Processing Charges (APCs), page charges, colour figure charges, or additional publication fees.

What types of scholarly contributions does TBM accept?

TBM welcomes high-quality original research articles, systematic reviews, meta-analyses, narrative reviews, methodological studies, brief communications, and scientific perspectives. The journal particularly encourages research focusing on biomarker discovery and validation, diagnostic and prognostic methods, therapeutic interventions, treatment response, molecular disease mechanisms, and clinically relevant outcomes.

What are the specific research areas TBM covers?

The journal's scope encompasses clinical and experimental biochemistry, targeted and untargeted metabolomics, multi-omics technologies, molecular diagnostics, oncology, pharmacology, toxicology, oral and dental health, clinical laboratory medicine, regenerative medicine, biotechnology, nutrition, metabolic disorders, bioinformatics, and computational approaches to biomedical research.

Where is TBM based and how can I reach the team?

The publisher is located in Sanliurfa, Türkiye, at Dagetegi Neighborhood, 8024th Street, AYM Residential Complex, Haliliye. The principal contact is Ismail Koyuncu, and the support contact is Ebru Temiz, who can be reached via the phone number +90 5438904954.

How does TBM handle open access and licensing?

The journal is licensed under a CC BY 4.0 Attribution 4.0 International Deed, which means all published articles are freely accessible to readers under the journal's open-access policy. This ensures that the research is available to anyone without cost.

What happens after a manuscript is accepted?

After acceptance, authors will be required to revise and format the manuscript fully in accordance with the final production requirements of TBM. Publication may be delayed until all requested formatting and documentation requirements have been completed, including ethical approval and informed-consent information where applicable.

What is the publication frequency and current status of TBM?

The current issue listed is Vol. 1 No. 1 (2026), published on 2026-10-14. The journal provides a multidisciplinary platform for basic, experimental, clinical, and translational studies investigating the biochemical, molecular, cellular, and metabolic mechanisms underlying health and disease.

What is the primary goal of TBM?

The journal aims to bridge fundamental scientific discoveries and clinical applications, promoting innovative approaches to disease prevention, early detection, diagnosis, prognosis, treatment, and personalized healthcare. It seeks to facilitate the translation of scientific knowledge into innovative diagnostic tools, effective therapeutic strategies, and meaningful improvements in human health.

Who is the intended audience for TBM?

TBM fosters collaboration among researchers, clinicians, dentists, pharmacists, and other healthcare professionals to advance interdisciplinary research in biochemistry, metabolomics, molecular medicine, clinical medicine, dentistry, pharmaceutical sciences, and related biomedical and health sciences.

What are the specific formatting requirements for initial submissions?

The submission file must be in OpenOffice, Microsoft Word, or RTF document file format. The text should be single-spaced, use a 12-point font, and employ italics rather than underlining, except for URL addresses.

What documents are required for the initial submission?

Authors must provide a complete manuscript, a title page with author and affiliation information, an abstract and keywords, the complete main text, all tables and figures, figure and table legends, references in any recognised citation style, ethical approval and informed-consent information where applicable, funding and competing-interest declarations, a data-availability statement, supplementary files where relevant, and the appropriate reporting checklist for the study design where applicable.

What technology and platforms does TBM use?

The journal hosts articles on platforms like OJS-Services.com, which provides support, journal hosting, and customization. The website domain is biometabolite.com, and it serves as a multidisciplinary platform for studies examining the biochemical and metabolic mechanisms of health and disease.

What is the current rating and review count for TBM?

The Trustburn rating is 3.8 out of 5 from 5 reviews. The journal is an international, peer-reviewed, open-access scientific journal dedicated to advancing interdisciplinary research in biochemistry, metabolomics, molecular medicine, clinical medicine, dentistry, pharmaceutical sciences, and related biomedical and health sciences.

AI-generated from reviews on this page. Verify anything important with the company directly.

Marcus Webb
Reviews 1

TBM covers an exciting range of topics, from mitochondrial metabolism to bioinformatics. The focus on translating molecular discoveries into precision-medicine applications is particularly engaging for clinical researchers.

Elena Rossi
Reviews 1

Translational Biochemistry and Metabolomics (TBM) offers a robust platform for scholarly contributions at the intersection of biochemistry, metabolomics, and clinical translation. The journal welcomes various formats, including original research, systematic reviews, and methodological studies, which caters to a diverse audience of experimental and computational scientists. Areas of interest such as lipidomics, biomarker discovery, and multi-omics integration are well-defined, suggesting a high standard of relevance for contemporary research. However, while the Aims & Scope and Author Guidelines are clearly outlined, the specific submission timelines and potential article processing charges are not immediately visible from the main navigation bar. For a researcher evaluating where to publish, having quick access to these logistical details would enhance the user experience. The open-access model under CC BY 4.0 is a significant advantage, promoting wider dissemination of findings. Overall, the journal seems well-positioned to advance molecular discoveries into diagnostic and therapeutic applications, though clearer upfront information on administrative details would be beneficial for new authors.

Martha Gable
Reviews 1

From the information available, TBM presents itself as an international peer-reviewed journal dedicated to advancing research at the interface of biochemistry and metabolomics. While the scope appears broad, covering areas like targeted metabolomics and clinical translation, the website does not clearly specify the exact costs associated with publishing or accessing certain features. For someone considering this journal, the absence of explicit pricing details in the main navigation creates uncertainty about financial obligations. Although a Price Policy is listed, the immediate visibility of costs remains insufficient for quick decision-making by prospective authors who need to budget accurately before submission.

Julian Thorne
Reviews 1

The availability of high-quality open-access content makes TBM a highly convenient resource for biochemists seeking to stay current with metabolomics and molecular medicine developments without additional paywalls.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Translational Biochemistry and Metabolomics (TBM)

Translational Biochemistry and Metabolomics (TBM) is an international, peer-reviewed, open-access journal that publishes research at the interface of biochemistry, metabolomics, molecular medicine, and clinical translation. It serves as a multidisciplinary platform for studies examining the biochemical and metabolic mechanisms of health and disease, with an emphasis on translating molecular discoveries into biomarkers, diagnostics, therapies, and precision-medicine applications. The journal accepts original research articles, systematic and narrative reviews, methodological studies, brief communications, perspectives, and other scholarly contributions in areas such as metabolomics, lipidomics, metabolic pathway analysis, biomarker discovery, mitochondrial metabolism, multi-omics integration, bioinformatics, and analytical method development. It is published using open-access principles and is licensed under a CC BY 4.0 Attribution 4.0 International Deed.

Categories
Publishing